The Importance of Colorectal Cancer Screening
Colon cancer doesn’t discriminate, it affects both men and women of all racial and ethnic groups. While it’s most common among individuals over the age of 50, there has been a rise in cases recorded in younger age groups as well. The good news is that when caught early, colorectal cancers are highly responsive to treatment with very good outcomes. To ensure you benefit from colorectal cancer’s excellent rate of success, it is important to understand your history and get screened.
Provider Brian M. Lingerfelt, MD, shared, “You should start getting screened for colorectal cancer around the age of forty-five. If you are at higher risk for developing colorectal cancer, plan to get screened much sooner and more frequently. Knowing your family history of colorectal cancer can help you determine your risk level and when is the appropriate time to schedule your first screening.”
If you had an appointment to get screened and it was postponed due to the onset of the pandemic, now would be a good time to contact your provider to reschedule. Cancer screenings have seen a significant decline as a result of the pandemic, making getting yours a priority today.
In addition to regular screenings, there are several lifestyle factors you can change to lower your risk. “Patients can lower their risk by maintaining a healthy weight, eating a healthy diet, and getting regular exercise. It sounds simple, but it can make a big difference in lowering your risk of developing colon cancer,” explained Dr. Lingerfelt.
For more information about colorectal cancer and screenings, visit our website or call one of our locations to schedule an evaluation.
Send UsA Message
Early-Stage Breast Cancer Characteristics and Treatment Options
Early-Stage Breast Cancer Characteristics and Treatment OptionsA rise in early-stage breast cancer diagnosis may result from better screening technology and a raised awareness of the importance of annual mammograms. An early-stage breast cancer diagnosis is contained...
Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World
Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”
Lowcountry doctors, patients helped secure ‘game-changer’ cancer treatment approval
Clinical trials for a newly-approved cancer treatment for lung cancer in the Lowcountry helped get the drug ready for people around the world, Lowcountry medical officials say.
Lowcountry Breast Cancer Survivors On Finding The Right Oncology Practice
How should one go about finding the right oncology practice? We interviewed ten Lowcountry breast cancer patients to get their perspectives and advice.
Sarcoma and Bone Cancer Awareness
July is Sarcoma and Bone Cancer Awareness Month. Sarcomas are a rare group of cancers in which malignant cells form in the bones or soft tissues of the body.
May is Skin Cancer Awareness Month
Melanoma is a type of skin cancer that develops when melanocytes start to grow out of control. Watch a video to learn more about melanoma from Dr. Charles S. Holladay.
